Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation-Reference-Cited by-同舟云学术

Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation

Published:2023-04 Issue: Volume:945 Page:175614
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Yu Xibao^ORCID,Liu Xin,Liu Xuan,Jin Shuang,Zhong Mengjun,Nie Dingrui^ORCID,Zeng Xiangbo,Wang Xianfeng,Tan Jiaxiong,Li Yangqiu^ORCID,Zeng Chengwu^ORCID

Funder

National Natural Science Foundation of China

Science and Technology Planning Project of Guangdong Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference46 articles.

1. Revisiting the differentiation paradigm in acute promyelocytic leukemia;Ablain;Blood,2011

2. Role of pyroptosis in cancer and its therapeutic regulation;Al Mamun;Eur. J. Pharmacol.,2021

3. Role of pyroptosis in diabetic retinopathy and its therapeutic implications;Al Mamun;Eur. J. Pharmacol.,2021

4. Targeting the SUMO pathway primes all-trans retinoic acid-induced differentiation of nonpromyelocytic acute myeloid leukemias;Baik;Cancer Res.,2018

5. Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1;Balusu;Blood,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a novel monocyte/macrophage-related gene signature for predicting survival and immune response in acute myeloid leukemia;Scientific Reports;2024-06-18

2. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential;Biomedicine & Pharmacotherapy;2024-06

3. Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells;Biochemical and Biophysical Research Communications;2024-05

4. Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro;Frontiers in Pharmacology;2024-02-01

5. CASP1 is a target for combination therapy in pancreatic cancer;European Journal of Pharmacology;2023-12